"Timing was right for sale of Synthes" video
Michel Orsinger, head of the orthopedics business of Johnson & Johnson (DePuy Synthes), talks with FuW on the state of integration of Synthes and the culture of the U.S. parent company.
The world's largest healthcare group Johnson & Johnson (J & J) is struggling with the integration of almost a year ago for $ 19.7 billionacquired Swiss-American orthopedic specialist Synthes. "We still have less than half of the necessary work done," says Michel Orsinger, head of the newly created business unit DePuy Synthes, frankly. In an interview w...
